Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Blood|October 23, 2023
Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and FranceFrancesco Peyronel, Julien Haroche, Corrado Campochiaro, et al.
Oncotarget|May 29, 2018
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphomaAlessandro Broccoli, Beatrice Casadei, Alice Morigi, et al.
Blood Cancer Journal|July 19, 2022
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian studyLivio Pagano, Marianna Criscuolo, Alessandro Broccoli, et al.
Hematological Oncology|January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient JourneyLisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
The Lancet. Haematology|October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort studyClaudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Oncotarget|December 7, 2017
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphomaCinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, et al.
Haematologica|August 5, 2017
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphomaAlessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Blood Cancer Journal|December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemiaFarhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Blood|April 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variantClive S Zent, Enrico Tiacci, Robert J Kreitman, et al.
Pageof 12